ELVN: Ball Kristine M reports a stock award
By AlphaYouPublished Form 4
BALL KRISTINE M
Reporting filer
Ball Kristine M reports a stock award, not an open-market purchase or sale, in Enliven Therapeutics, Inc.. Form 4 filed Oct 16, 2026 lists 1 entry.
- Disclosed
- Oct 16, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) (derivative) | BALL KRISTINE M | 2026-10-14 | A | Grant or award | 23394 | 0 | 23,394 | 2 days | Filed terms
|
Stock Option (right to buy) (derivative)
- Owner
- BALL KRISTINE M
- Date
- 2026-10-14
- Code
- A
- Action
- Grant or award
- Quantity
- 23394
- Price
- 0
- Following holdings
- 23,394
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 39.28
- transaction Date: 2026-10-14
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 23394
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-14
- underlying Security Title: Common Stock
- underlying Security Shares: 23394
- shares Owned Following Transaction: 23394
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- BALL KRISTINE M: Director.
- F1: 1/36th of the shares subject to the option will vest on November 14, 2026 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date.
Original sources
Prepared automatically from public filing data. Report a correction.